Patent · US Expired

Therapeutic uses of actin-binding compounds

US5260224A · kind A · utility

43Cited by

0References

1Claims

0Family size

Assignee

The Brigham and Women's Hospital, Inc. · US

Inventors

Thomas P. Stossel · Belmont, US
Stuart E. Lind · Belmont, US
Paul A. Janmey · Arlington, US

Key dates

Filing date	Oct 10, 1991
Grant date	Nov 9, 1993
Priority date	—
Expiry date	Oct 10, 2011

Classification

Technology area (CPC G)Physics
CPC primaryG01N33/6893
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

A method for decreasing the concentration of free actin in the plasma of an animal is described which comprises the administration of native and modified actin-binding proteins, and especially the administration of native and modified actin-binding regions of gelsolin. Diagnostic methods for identifying animals in need of such treatment are also described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.